GSK in talks to buy cancer biotech Nuvalent for more than $9bn



The joint venture will become one of the UK’s biggest drugmakers as biotech M&A activity has been buoyed this year.



Source link

اترك ردّاً

لن يتم نشر عنوان بريدك الإلكتروني. الحقول الإلزامية مشار إليها بـ *